Controversy over new data on oral contraceptives

BMJ 1995; 311 doi: 10.1136/bmj.311.7014.1228c (Published 4 November 1995)
Cite this as: BMJ 1995;311:1228.4

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. A Rouse
  1. Senior lecturer in health studies Nene College, School of Health and Life Sciences, Northampton NN2 7AL

    Risk of delay was small

    EDITOR,--The rapidity with which the Committee on Safety of Medicines released its advice about the risk of thromboembolism associated with oral contraceptives has caused much anger, concern, and confusion.1 Critics of the committee maintain that (a) systems exist for the rapid dissemination of information to medical practitioners, (b) these systems could have disseminated information to medical practitioners within 12-48 hours, and …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL